Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Title
Created Date
Cancer research: Are the drugs we count on based on bad science?
27 October 2013
How effective is chemo therapy?
07 October 2013
Long-term side-effects. Molecularly targeted therapies hold promise for many pediatric cancers, but at what cost?
19 July 2013
Are we treating cancer, but killing the patient?
06 April 2013
Radiation generates cancer stem cells from less aggressive breast cancer cells!
22 February 2013
Melatonin's role in cancer
17 January 2013
Chemo can backfire, make cancer worse!
12 December 2012
Display #
5
10
15
20
25
30
50
100
All
Search
Follow us...
Latest
MELATONIN AND COLORECTAL CANCER: THE RISE OF STANDARD TREATMENT EFFICACY
MELATONIN ENHANCES TEMOZOLOMIDE-INDUCED APOPTOSIS IN GLIOBLASTOMA AND NEUROBLASTOMA CELLS
Melatonin Induces AGS Gastric Cancer Cell Apoptosis via Regulating PERK/eIF2α and HSF1/NF-κB Signaling Pathway
Melatonin, circadian rhythms and breast cancer
Melatonin in dental practice: applications and prospects (literature review)
Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53-SIRT1 dependent pathway
Melatonin Mitigates the Progression of Chemically Induced Hepatocellular Carcinoma in Rats via Targeting Wnt/Β-Catenin Pathway, and Small Noncoding miR-let-7b
Melatonin - known problems and perspectives of clinical usage
MELATONIN: POTENTIAL UTILITY FOR IMPROVING PUBLIC HEALTH
Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
Melatonin: action as antioxidant and potential applications in human disease and aging
Melatonin: an established antioxidant worthy of use in clinical trials
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Melatonin and Cancer Hallmarks
Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders
Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans
Melatonin as antioxidant, geroprotector and anticarcinogen
Most Read
The Di Bella Method (DBM)
All-trans-retinoic acid and cancer
About melatonin - 1996
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Somatostatin in oncology, the overlooked evidences
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Bibliography
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
How effective is chemo therapy?
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
Vademecum
Complete objective response to biological therapy of plurifocal breast carcinoma
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients